Global Medical Cosmetology Product Market Insights and Forecast to 2028

Market Analysis and Insights: Global Medical Cosmetology Product Market
Due to the COVID-19 pandemic, the global Medical Cosmetology Product market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Hyaluronic Acid accounting for % of the Medical Cosmetology Product global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Medical Cosmetology Product market size is valued at US$ million in 2021, while the US and Europe Medical Cosmetology Product are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Medical Cosmetology Product landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Medical Cosmetology Product include HUONS, Allergan, Galderma, MEIK Technology Development, Merz Pharma, DAEWOONG, Bloomage Biotech, Shanghai Haohai Biological Technology and Lanzhou Institute of Biological Products, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Medical Cosmetology Product Scope and Segment
Medical Cosmetology Product market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Medical Cosmetology Product market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Hyaluronic Acid
Botulinum Toxin
Others
Segment by Application
Hospital
Clinic
Others
By Company
HUONS
Allergan
Galderma
MEIK Technology Development
Merz Pharma
DAEWOONG
Bloomage Biotech
Shanghai Haohai Biological Technology
Lanzhou Institute of Biological Products
Q-MedAB
Bomengrun Biological Technology
YVOIRE LG Life Sciences
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E